oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes Comparative of to dulaglutide patients with VisualAbstract: Semaglutide Improves Outcomes in

GLP-1 shows anti-inflammatory properties in pancreatic islets and adipose tissue, contributing to lower glucose levels in diabetic patients 22,23

Jan 2020;159(1):R1-R13

Caramori G, Casolari P, Barczyk A, Durham AL, Di Stefano A, Adcock I

Study author Patricia Rodriguez, PhD, MPH, principal applied scientist at Truveta, which partly funded the study, noted the following additional highlights of the studys findings, to MNT : Patients on tirzepatide were over two times more likely to experience 10% weight loss and three times more likely to experience 15% weight loss within a year, compared to patients on semaglutide

Hofkens et al [26] showed that liposomal prednisolone phosphate reduced the proinflammatory macrophages activation in vivo [26, 27]

Pan E, Zhang XA, Huang Z, Krezel A, Zhao M, Tinberg CE, Lippard SJ, McNamara JO